A Study of mRNA-1083 (SARS-Cov-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
Conditions: SARS-CoV-2; Influenza Interventions: Biological: mRNA-1083; Biological: Placebo; Biological: Influenza Vaccine; Biological: COVID-19 Vaccine Sponsors: ModernaTX, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Covid Vaccine | COVID-19 | Influenza | Influenza Vaccine | Research | SARS | Study | Vaccines